Oruka Therapeutics, Inc. (ORKA)
Who owns Oruka Therapeutics, Inc. (ORKA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.7% of the shares are freely tradable; institutional investors hold 89.1%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 12.32 | 7,431,403 | +2.3 | 03/31/2026 |
| VR Adviser, LLC | 6.88 | 4,148,428 | +0.0 | 03/31/2026 |
| Fairmount Funds Management LLC | 6.14 | 3,705,262 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.85 | 3,527,087 | -0.3 | 03/31/2026 |
| Viking Global Investors LP | 4.42 | 2,666,690 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 4.07 | 2,453,530 | +38.1 | 12/31/2025 |
| Paradigm Biocapital Advisors LP | 3.85 | 2,320,316 | +35.7 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 3.41 | 2,058,148 | +0.0 | 03/31/2026 |
| Deep Track Capital, LP | 3.37 | 2,034,203 | -5.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.08 | 1,859,631 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Goncalves Joana | Chief Medical Officer | Sell | 300 | 87.25 | 26,176 |
| 15. Jul 2026 | Goncalves Joana | Chief Medical Officer | Sell | 3,803 | 86.68 | 329,630 |
| 15. Jul 2026 | Goncalves Joana | Chief Medical Officer | Sell | 2,497 | 85.86 | 214,385 |
| 15. Jul 2026 | Goncalves Joana | Chief Medical Officer | Sell | 400 | 84.37 | 33,746 |
| 15. Jul 2026 | Goncalves Joana | Chief Medical Officer | Other | 3,500 | 7.80 | 27,300 |
| 13. Jul 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 5,656 | 84.90 | 480,201 |
| 13. Jul 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 3,743 | 84.26 | 315,369 |
| 13. Jul 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 300 | 85.63 | 25,690 |
| 13. Jul 2026 | Agarwal Arjun | Senior Vice President, Finance | Other | 1,458 | 34.39 | 50,141 |
| 13. Jul 2026 | Agarwal Arjun | Senior Vice President, Finance | Other | 8,541 | 12.50 | 106,763 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.